Filamin A binding proteins and uses thereof
US10759850B2 · kind B2 · utility
1Cited by
0References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 1, 2017 |
| Grant date | Sep 1, 2020 |
| Priority date | — |
| Expiry date | Nov 1, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/96455
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention encompasses filamin A (FLNA) binding proteins. Specifically, the invention relates to antibodies to FLNA. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. Methods of making and methods of using the antibodies of the invention in methods of diagnosis, monitoring and prognosis of prostate cancer are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.